oral JH2-binding Tyk2 inhibitor
Ph. I in psoriasis complete
backup candidate to BMS-986165 for psoriasis
J. Med. Chem., Dec. 28, 2020
Bristol-Myers Squibb, Princeton, NJ
BMS-986202
Bristol Myers Squibb (BMS) oral JH2-domain binding Tyk2 kinase inhibitor